Both Semaglutide and Mounjaro represent groundbreaking approaches to treating type 2 diabetes, and increasingly, obesity. Tirzepatide is a combined molecule that works on multiple receptors involved in metabolism: GLP-1 and another incretin. It, often considered as a trade name for this compound,